Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Trump, Kamala Harris and UBS
UBS Poll: Wealthy Investors Favor Harris, Business Owners Prefer Trump
The latest poll from the brokerage giant finds the economy is the top issue for affluent investors as well as business owners.
Millionaire Investors Prefer Harris To Trump, UBS Poll Says
But in an accompanying survey, 500 owners of businesses with annual revenues above $1 million leaned toward Trump, favoring his tax proposals.
Wealthy investors support Harris over Trump, new survey says
According to a UBS survey of investors with at least $1 million of investible assets, 57% plan to vote for Harris and 43% plan to vote for Trump.
GE HealthCare, UBS
UBS Downgrades GE HealthCare Technologies (BVC:GEHC)
Fintel reports that on September 26, 2024, UBS downgraded their outlook for GE HealthCare Technologies ( BVC:GEHC) from Neutral to Sell. What is the Fund Sentiment?
BTIG upgrades GE Healthcare Technologies Inc (GEHC) to a Buy
In a report released yesterday, Ryan Zimmerman from BTIG upgraded GE Healthcare Technologies Inc (GEHC – Research Report) to a Buy, with
UBS Downgrades GE HealthCare Technologies (GEHC)
Fintel reports that on September 26, 2024, UBS downgraded their outlook for GE HealthCare Technologies (NasdaqGS:GEHC) from Neutral to Sell. Analyst Price Forecast Suggests 5.77% Upside As of September 25,
19h
on MSN
UBS in talks on Indian minority-owned wealth joint venture, say sources
UBS is in talks to form an Indian wealth management joint venture with Mumbai-based 360 One WAM, two sources with direct ...
Financial Planning
3h
Majority of wealthy investors plan portfolio changes ahead of election, UBS finds
A recent UBS Investor Watch report highlights a deeply divided country in which many view the economy as the main issue this ...
1h
UBS initiates 'sell' calls on slew of pharma majors; sees growth slowdown in India & US mkts
UBS initiated 'sell' calls on Dr Reddy's Laboratories Lupin, Aurobindo Pharma and Zydus Lifesciences while picking Sun Pharma ...
12h
on MSN
Italy picks UBS Europe, White & Case as advisers for Poste stake sale
Italy's Treasury said on Friday it had picked UBS Europe SE and White & Case Europe LLP as financial and legal advisers for ...
bovnews
16h
UBS Just Downgraded SSR Mining Inc (SSRM) Stock—What Does This Mean for Investors?
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.10% of ...
1d
Mexico’s Peso to Gain as Political Uncertainty Ebbs, UBS Says
Mexico’s peso is set to strengthen through the first half of next year as investors grow more comfortable with the new ...
3h
Brokerage Radar: UBS favours Sun Pharma, Cipla; Morgan Stanley sees relief for IT sector
Check out the latest brokerage calls and analyst comments on the stocks in action today. Our coverage includes real estate, ...
7d
on MSN
UBS Loses $2.8 Billion Advisor Team to RBC Wealth Management
The latest addition to RBC’s growing wealth operation is a 15-person team that is joining the firm’s Atlanta office.
2d
UBS Sticks to Their Buy Rating for Visa (V)
UBS analyst Timothy Chiodo maintained a Buy rating on Visa (V – Research Report) today and set a price target of $320.00. The ...
14h
Certara gains as UBS upgrades citing compelling buy
Certara (CERT) stock rises 10% after UBS upgrade to Buy citing strong growth potential in biosimulation software and Model ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Wealth management
Sergio Ermotti
Feedback